Valcyte not to be used for liver transplant patients

10/28/2003 | Medscape (free registration)

The FDA has advised health care professionals not to use the drug for those patients, and has not delineated how safe or effective it is to use for the prevention of cytomegalovirus disease in other organ transplant cases. The medication is currently used for high-risk kidney, heart and kidney-pancreas patients.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA